Shares of Ocugen Inc. /zigman2/quotes/208160861/composite OCGN +5.76% slid 5.90% to $7.65 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +2.43% falling 0.26% to 4,688.67 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.65% falling 0.58% to 35,931.05. This was the stock's third consecutive day of losses. Ocugen Inc. closed $11.12 short of its 52-week high ($18.77), which the company achieved on February 8th.
The stock underperformed when compared to some of its competitors Wednesday, as Adverum Biotechnologies Inc. /zigman2/quotes/210484271/composite ADVM +3.33% fell 0.93% to $2.13, Ocular Therapeutix Inc. /zigman2/quotes/207607068/composite OCUL +2.10% fell 4.69% to $6.71, and Kodiak Sciences Inc. /zigman2/quotes/207655028/composite KOD +5.34% fell 5.43% to $102.10. Trading volume (12.9 M) remained 25.1 million below its 50-day average volume of 38.0 M.